Orphanet: Pesquisa por doença/gene
x

Pesquisar um projeto de investigação

* (*) campo(s) de preenchimento obrigatório

159 Resultado(s)

Ordenados por

Financiado por um membro do IRDiRC = Membro de uma ERN =

Projetos de investigação

ALEMANHA

Nordrhein-Westfalen
BONN

ALEMANHA

Nordrhein-Westfalen
MÜNSTER

Functional role of genes and pathways in histone H3 mutated gliomas
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

ALEMANHA

Rheinland-Pfalz
MAINZ

GLIOPT -Glioma patients in ambulatory care - Optimization of psychosocial care in neurooncological patients
Universitätsmedizin Mainz
Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

AUSTRIA

WIEN
WIEN

Improved Visualization and Resection of Brain Tumors with Quantitative Fluorescence and Optical Coherence Tomography
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

AUSTRIA

WIEN
WIEN

Magnetic Resonance Fingerprinting of Patients with Gliomas
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

ESTADOS UNIDOS

South Dakota
SIOUX FALLS

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

IRLANDA

County Dublin
DUBLIN

PORTUGAL

SUL
LISBOA

Papel da proteína cinase WNK2 como gene supressor de gliomas malignos
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Unidade de Investigação e Desenvolvimento

REINO UNIDO

Greater London
LONDON

SUECIA

Region Uppsala
UPPSALA

Molecular mechanisms of the origine of glioma development
Uppsala Universitet
Department of Immunology, Genetics and Pathology

SUICA

Suisse Alémanique
BERN

Metabolic Characterization of Space Occupying Lesions of the Brain Using in Vivo MR- (Spectroscopic) Imaging at 3 Tesla and 7 Tesla
University Hospital Inselspital
Universitätsinstitut für Diagnostische und Interventionelle Neuroradiologie

ALEMANHA

Baden-Württemberg
HEIDELBERG

Financiado por um membro do IRDiRCERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

ALEMANHA

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

ALEMANHA

Hamburg
HAMBURG

International HIT-MED Registry (I-HIT-MED) for Children, Adolescents, and Adults With Medulloblastoma, Ependymoma, Pineoblastoma, CNS-primitive Neuroectodermal Tumour
UKE - Universitätsklinikum Hamburg-Eppendorf
Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie

ALEMANHA

Nordrhein-Westfalen
MÜNSTER

Clinical and molecular features predicting outcome in children with atypical teratoid/rhabdoid tumour (AT/RT)
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

AUSTRIA

WIEN
WIEN

Financiado por um membro do IRDiRCBRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Kinder- und Jugendheilkunde

AUSTRIA

WIEN
WIEN

Financiado por um membro do IRDiRCITCC-P4: Pediatric Preclinical Proof of Concept Platform - AT
Medizinische Universität Wien
Institut für Krebsforschung

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

CANADA

Ontario
TORONTO

Financiado por um membro do IRDiRCMolecular Determinants of Li-Fraumeni Syndrome Associated Cancers
Hospital for Sick Children, Research Institute

CANADA

Ontario
TORONTO

CANADA

Québec
MONTRÉAL

Financiado por um membro do IRDiRCIdentification and characterization of genes involved in the genesis and progression of pediatric astrocytomas
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Financiado por um membro do IRDiRCRole of chromatin remodeling in the genesis of pediatric and young adult astrocytomes
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Financiado por um membro do IRDiRCThe ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

ESTADOS UNIDOS

South Dakota
SIOUX FALLS

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCPrecision medicine for pediatric low-grade gliomas
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCRegulation of medulloblastoma metastasis by emp1
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCRegulation of shh signaling by cellular energetics
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCTargeting mechanisms of medulloblastoma formation
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCTargeting wee1 in myc driven medulloblasoma
Institution: Information not provided - US

FRANCA

ILE-DE-FRANCE
ORSAY

DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

FRANCA

ILE-DE-FRANCE
VILLEJUIF

Financiado por um membro do IRDiRCBRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - FR (Partener 1)
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

ITALIA

VENETO
PADOVA

Financiado por um membro do IRDiRCModulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS

SUECIA

Region Stockholm
STOCKHOLM

Novel targeted therapy for childhood cancer with emphasis on Wip-1 in medulloblastoma and neuroblastoma
Karolinska Institutet - Solna
Department of Women's and Children's Health

SUECIA

Region Stockholm
STOCKHOLM

INTENT: innovative approach for treatment of neuroblastoma and medulloblastoma
Karolinska Institutet - Solna
Department of microbiology, tumor and cell biology

ALEMANHA

Nordrhein-Westfalen
KÖLN

Molecular basis for tumor suppression and spontanous regression in neuroblastoma
Universitätsklinikum Köln
Pädiatrische Onkologie und Hämatologie

ALEMANHA

Sachsen
LEIPZIG

NB-MolBiol-2020: Study on the clinical significance of cell biological parameters in diagnostics, prognosis and therapy for neuroblastoma patients
Zentrum für Frauen- und Kindermedizin am Universitätsklinikum Leipzig
Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie

AUSTRIA

SALZBURG
SALZBURG

Adjuvant multimodal metabolic therapy of neuroblastoma
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Kinder- und Jugendheilkunde

AUSTRIA

WIEN
WIEN

Identifying immunological characteristics associated with disease progression in low grade glioma
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

AUSTRIA

WIEN
WIEN

Quantitative measurement of 5-ALA fluorescence for improved detection of low-grade gliomas
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

AUSTRIA

WIEN
WIEN

Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors - a pilot study
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für klinische Pharmakologie

AUSTRIA

WIEN
WIEN

COREIA DO SUL

KOREA, REPUBLIC OF
SEOUL

ESPANHA

Cataluña
BARCELONA

Targeting kinesins as new therapeutic approach for high-risk neuroblastoma patients
Vall d'Hebron Institut de Recerca VHIR
Grupo de investigación traslacional en cáncer en la infancia y la adolescencia

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCTargeting olig2 co-regulators for malignant glioma therapy
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCDrug repurposing screening for rare and neglected diseases
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCDeconstruct tumor microenvironment in medulloblastoma
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCTargeting bet-bromodomains in neuroblastoma
Institution: Information not provided - US

FINLANDIA

Finland
HELSINKI

Financiado por um membro do IRDiRCLessons learned from the embryo to help understand neuroblastoma formation
University of Helsinki
Department of Biochemistry and Developmental Biology

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCA

AUVERGNE-RHONE-ALPES
LYON

ALEMANHA

Nordrhein-Westfalen
DÜSSELDORF

Targeting HOTAIRM1 in Glioblastoma Multiforme
Universitätsklinikum Düsseldorf
Hirntumor-Referenzzentrum der DGNN

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
WIEN

TERT promoter mutations and cancer aggressiveness
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

AUSTRIA

WIEN
WIEN

AUSTRIA

WIEN
WIEN

Fibroblast Growth Factor Receptor 4 in Glioblastoma
Medizinische Universität Wien
Institut für Krebsforschung

ESPANHA

Cataluña
BADALONA

ESPANHA

Cataluña
ESPLUGUES DE LLOBREGAT

Characterize the behaviours and identify patterns of paediatric rare tumours
Fundació Sant Joan de Déu - Institut de Recerca Sant Joan de Déu
Patients Engagement in Research Area

ESPANHA

Comunidad Valenciana
VALENCIA

Financiado por um membro do IRDiRCIntegrative personal omics profiles in glioblastoma recurrence and therapy resistance
IIS La Fe - Instituto de Investigación Sanitaria La Fe
GIBI230: Grupo de Investigación Biomédica en Imagen

ESPANHA

País Vasco
SAN SEBASTIÁN

Financiado por um membro do IRDiRCTherapeutic strategy of inactivation of glioma stem cells through the silencing of its SOX1 marker
Instituto de Investigación Sanitaria Biodonostia
Grupo de oncología celular

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCImmunobiology of malignant glioma
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCComparative mammalian genomics
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCGlioblastoma stem cell-derived pericytes and cancer invasion
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCModeling malignant progression in glioma
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCNeuronal activity-regulated mechanisms of glioma growth
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCNeuroimmunology of malignant brain tumors: innate mechanisms
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCRole of glud2 as a metabolic driver of gliomas with idh1 mutations
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCSystemic gene therapy for glioblastoma
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCThe mayo gbm xenograft national resource
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCTargeting epha2 in glioblastoma
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCSelective targeting of glioma stem cells through sema3c/plexind1
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCUbiquitination and deubiquitination of c-myc in glioblastoma
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCChromatin modifications in gbm-propagating cells
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCCellular plasticity and equilibrium in gbm progression
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCExploiting mtap deletion for gbm therapeutics
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCMechanisms of riok2 function in glioblastoma
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCThe role of tumor associated macrophages in glioblastoma
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCTargeting kif11 to treat glioblastoma invasion and proliferation
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCPhysical-chemical aspects of cell and tissue excitability
Institution: Information not provided - US

ESTADOS UNIDOS

Washington
ADDRESS: NOT PROVIDED - US

Financiado por um membro do IRDiRCTherapeutically relevant targets of twist1 dimers in glioma
Institution: Information not provided - US

FINLANDIA

Finland
KUOPIO

New therapeutic treatments for malignant glioma
Itä-Suomen yliopisto
A.I.Virtanen -Instituutti

FINLANDIA

Finland
KUOPIO

Financiado por um membro do IRDiRCLAT1-targeted prodrugs for improved drug delivery to invasive glioma cells
University of Eastern Finland
Faculty of Health Sciences

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCA

AUVERGNE-RHONE-ALPES
ILLKIRCH

Systems biology of integrin inhibition-induced apoptosis for novel glioblastoma treatment
LBP - Laboratory of Bioimaging and Pathologies
Tumoral signaling and therapeutic targets

FRANCA

AUVERGNE-RHONE-ALPES
LYON

Identification of networks of alternative splicing events that coordinate cell heterogeneity and resistance to glioblastoma therapies
Centre de Recherche en Cancérologie Lyon-Est
Diversité du transcriptome des cellules souches

FRANCA

BRETAGNE
RENNES

Tumor activity of IRE1 and remodeling of the immune microenvironment of glioblastomas
Centre de Lutte Contre le Cancer Eugène Marquis
Oncogenesis, Stress & Signaling Laboratory

FRANCA

NORMANDIE
CAEN

Radiosensitization and reoxygenation of tumors via zeolites containing gadolinium: an original theranostic approach for glioblastomas
GIP CYCERON
Equipe CERVOxy | Hypoxie, physiopathologies cérébrovasculaire et tumorale

FRANCA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Development of a new drug therapy for glioblastoma
Parc scientifique et technologiques de Luminy
Pharmaxon

PORTUGAL

CENTRO
BRAGA

REINO UNIDO

Cambridgeshire
CAMBRIDGE

Projetos de investigação multicêntricos